Drug
Biib021
Biib021: highest development phase Phase 2, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| BIIB021 NCT01004081 | Phase 2 | Breast Cancer |
Latest
No recent events.
Follow Biib021 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.